NCT07283718进行中（未招募）不适用
The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis：a Real-world Study
Wenjin Yin2 个研究点 分布在 1 个国家目标入组 2,467 人开始时间: 2025年9月28日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,467
- 试验地点
- 2
- 主要终点
- Disease free survival
研究概览
简要总结
This is a real-world multicentre study to investigate the metastatic pattern of axillary lymph node and its association with breast cancer prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 18 years or older
- •Pathologically confirmed invasive primary breast cancer
排除标准
- •De novo stage IV breast cancer
结局指标
主要结局
Disease free survival
时间窗: From the date of ALND until time of event up to 3 years
Disease-free survival time is defined as the time from the date of axillary lymph node dissection until the date of the first occurrence of local/regional relapse, distant recurrence, contralateral breast cancer, second malignancy and death from any cause.
次要结局
- Recurrence-free survival(From the date of ALND until time of event up to 3 years)
- Overall survival(From the date of ALND until time of event up to 3 years)
研究者
Wenjin Yin
Deputy Chief of Breast Surgery Department
RenJi Hospital
研究点 (2)
Loading locations...
相似试验
尚未招募
不适用
Shanghai Lymphoma Clinical CohortLymphomaNCT07285174Ruijin Hospital1,000
招募中
2 期
KEYMAKER U01 Sub-Study E Signal-finding study to test investigational agents with pembrolizumab in combination with chemotherapy in newly diagnosed NSCLC in a rolling arm design2023-509234-19-00Merck Sharp & Dohme LLC47
招募中
不适用
Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort StudyNCT07270861Fudan University3,000
招募中
3 期
AMX0035 and Progressive Supranuclear Palsy2023-505893-14-00Amylyx Pharmaceuticals Inc.269
招募中
3 期
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418).
Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of active post-resection/ ablation therapy in patients with metastatic colorectal cancer.2024-512174-10-00Charite Universitaetsmedizin Berlin KöR507